Catalina Capital Group’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $461K | Sell |
2,482
-767
| -24% | -$142K | 0.3% | 67 |
|
|
2025
Q1 | $681K | Sell |
3,249
-7,421
| -70% | -$1.56M | 0.45% | 50 |
|
|
2024
Q4 | $1.9M | Buy |
10,670
+557
| +6% | +$99K | 0.62% | 33 |
|
|
2024
Q3 | $2M | Buy |
10,113
+903
| +10% | +$178K | 0.67% | 31 |
|
|
2024
Q2 | $1.58M | Buy |
9,210
+2,292
| +33% | +$393K | 0.59% | 33 |
|
|
2024
Q1 | $1.26M | Buy |
6,918
+3,628
| +110% | +$661K | 0.52% | 39 |
|
|
2023
Q4 | $510K | Buy |
+3,290
| New | +$510K | 0.34% | 54 |
|